HealthDay on MSN1d
Pre-Exposure Prophylaxis Use Increased in Recent YearsPrEP use increased between 2013 and 2023, according to a research letter published online in the Journal of the American Medical Association.
Historically, as mentioned, PrEP has been used to treat cisgender gay men, especially in light of the HIV crisis of the 1980s ...
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...
Harmony Garges, M.D, senior vice president, chief medical officer and head of global medical at ViiV Healthcare, highlighted ...
With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
Pre-exposure prophylaxis (PrEP) with antiretroviral medications is effective in preventing HIV infections. PrEP use has increased between 2013 and 2023. Multiple PrEP medications are ...
News Medical on MSN2d
Affordability and supply remain critical to the success of long-lasting HIV drugAffordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Mexican army troops have killed 19 suspected drug cartel gunmen in a shootout but suffered no casualties themselves.
Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback